Pharmaceutical Commerce - July/August 2013 - (Page 4)

Table of Contents VOL. 8, NO. 4 15 3 Editorial How about a US Chamber of Healthcare Commerce? The full range of healthcare manufacturers should have a unified voice 6 Op-Ed Medical Affairs’ changing role in market access and reimbursement Outsourced facilities management saves precious financial resources Life sciences companies—including mid-market ones—are finding value in an outsourced service 8 Top News IMS Use of Medicines report: 2012 sales drop 1.0%—the first ever recorded decline Annual study sees the end of the “generics bubble” and worrisome trends in consumer utilization of healthcare More cold-chain facilities open up around the world Panalpina, LuxairCargo, UPS have new warehouse capacity; DHL upgrades facilities and depots for life sciences shipping PhRMA CEO, John Castellani, joins the advisory board of a new contract sales organization, Pharmacist Partners Company is building a network of pharmacist consultants to help market to healthcare providers AmerisourceBergen’s Steve Collis: ‘This is not about shortterm results’ Following its pathbreaking alliance with Walgreens/Alliance Boots, AmerisourceBergen is busy executing its future plans Another go at medication-adherence collaborations—but this one might make a difference Council for Affordable Health Coverage brings many healthcare groups together Moving up the marketing maturity curve Given the profound changes in the pharmaceutical commercial model, sales and marketing must deliver integrated customer experiences across channels and adapt through real-time insights Life-sciences CRM vendors direct their attention to the Microsoft platform Veeva and Cegedim roll out Windows 8 versions of their products HDMA elects new directors to its board; Boehringer Ingelheim exec wins Nexus Award Attain Med, Inc., KeySource Medical, and Top Rx now represented in HDMA leadership Business/Finance Overcoming operational silos in pharma revenue management Disconnected business processes in contract administration, managed markets, rebates, sales compensation and related areas cause waste and inefficiency for company management Biosimilars: It’s a matter of time For global markets, there is a need to balance the imperative to get to market quickly against the evolving regulatory landscape Founder and Editor in Chief Nicholas Basta, 718 282 6112 Contributing Editors Lena Anthony, F.J. Quinn, Bob Sperber, Suzanne Shelley, Peggy Wright Editorial Board Jeffrey Berkowitz, Walgreens Richard Carlson, Blue Fin Group Liz Coyle, IMS Health Adam Fein, Pembroke Consulting Rich Minoff, 1 Global Partners Mark Seitz, Eli Lilly & Co. Robert Zachow, Bracco Diagnostics Advertising Sales Senior Vice President and Publisher Clifford P. Tallman, Jr., 203 831 0771 Optimizing hub services with the power of cloud and mobile Cloud-based IT technologies are a natural fit for patientsupport hubs New England Vince Cavaseno, 617 232 2000 Jody Estabrook, 774 283 4528 At ASCO meeting, McKesson showcases US Oncology capabilities Demonstration of second-generation IKnowMed EHR; over 90 studies involve US Oncology Network researchers Midwest David Gerchen, 314 878 3939 Southeast Cathy Williams, 843 410 2739, ext. 101 SkilaMederi and Qforma merge, hoping to make a powerhouse in prescriber-influence analytics Merger combines Qforma’s local analytics with SkilaMederi’s national perspective 20 Supply Chain/Logistics Cold Chain GDP & Temperature Management Logistics Global Forum 22 Information Technology Preparing for a serialized supply chain Upcoming California regulatory mandates, and the prospect of a national compliance requirement, are focusing industry attention. Here’s what some industry leaders have to say 24 11 Brand Marketing & Communications Manufacturing & Packaging Drug labels acquire more functionality to improve health outcomes Besides the ongoing debate over serialization, drug labels are playing a greater role in anti-counterfeiting, preventing medication errors and improving patient adherence 27 Legal & Regulatory The value of real-world data in drug commercialization Using real-world databases for evidence development has strengths and weaknesses; with electronic health records (EHRs), new approaches are evolving PDMA Alliance: Change is the new norm NABP is on its way to owning the .Pharmacy domain suffix (gTLD) Group passes the initial ICANN evaluation; will NABP be the international policeman of online pharmacies? 31 4 Visit our website at July | August 2013 Meetings and Editorial Index West Richard Ayer, 949 366 9089 Advertising Production Heidi Nelson, 203 852 6570, ext. 228 Circulation and Administration Senior Vice President and General Manager David Soskin, 203 831 0711 Reprints, Research and Custom Publishing David Soskin, 203 831 0711 Circulation Subscription Changes Jennifer Lee, 800 437 7456 Healthcare Commerce Media Corporation Pharmaceutical Commerce is published by Healthcare Commerce Media Corp. 85 Westminster Rd., Brooklyn, NY 11218. Editorial/Advertising Queries: 718 282 6112, or Copyright 2013. All rights reserved. Printed in the United States of America. Send all subscription inquiries or requests to Subscriptions, Pharmaceutical Commerce, 151 Fairchild Avenue, Plainview, NY 11808-1709, Tel: 800 437 7456. Fax: 516 908 3802 The management and editors of Pharmaceutical Commerce make every effort to publish accurate information. However, neither the management, editorial board, editors or reporters can be held liable for erroneous information. Opinions of Pharmaceutical Commerce columnists are their own, and do not necessarily represent those of employees or other contributors to Pharmaceutical Commerce.

Table of Contents for the Digital Edition of Pharmaceutical Commerce - July/August 2013

Pharmaceutical Commerce - July/August 2013
Top News
Brand Marketing & Communications
Supply Chain/Logistics
Information Technology
Manufacturing & Packaging
Legal & Regulatoryv
Meetings and Editorial Index

Pharmaceutical Commerce - July/August 2013